Shares of ReWalk Robotics Ltd. (NASDAQ:RWLK) saw strong trading volume on Wednesday . 139,151 shares changed hands during mid-day trading, an increase of 5% from the previous session’s volume of 132,197 shares.The stock last traded at $5.99 and had previously closed at $6.09.

Several research analysts have recently commented on the company. Jefferies Group reissued a “buy” rating and issued a $16.00 price target on shares of ReWalk Robotics in a research report on Sunday, May 8th. Zacks Investment Research lowered ReWalk Robotics from a “buy” rating to a “hold” rating in a research report on Thursday, July 7th. Piper Jaffray Cos. assumed coverage on ReWalk Robotics in a research report on Friday, July 15th. They issued an “overweight” rating and a $10.00 price target for the company. Finally, Canaccord Genuity reissued a “buy” rating on shares of ReWalk Robotics in a research report on Sunday, August 7th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $12.80.

The firm’s market cap is $74.64 million. The stock’s 50-day moving average is $6.66 and its 200 day moving average is $8.25.

ReWalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings results on Thursday, August 4th. The medical device company reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.11. The business had revenue of $0.82 million for the quarter, compared to the consensus estimate of $1.95 million. The company’s revenue for the quarter was up 34.4% on a year-over-year basis. On average, equities research analysts predict that ReWalk Robotics Ltd. will post ($2.34) earnings per share for the current fiscal year.

In other news, major shareholder Scp Vitalife Partners Ii Lp sold 20,256 shares of the stock in a transaction that occurred on Thursday, May 26th. The shares were sold at an average price of $8.69, for a total value of $176,024.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeff Dykan sold 27,022 shares of the stock in a transaction that occurred on Thursday, May 26th. The shares were sold at an average price of $8.69, for a total transaction of $234,821.18. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.